| 1 |
35977101 |
10.1182/blood.2022016056 |
2022 |
Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma. |
KDR |
| 2 |
32997825 |
10.1111/ejh.13526 |
2021 |
VEGFR2 and VEGFA polymorphisms are not associated with an inferior prognosis in Caucasian patients with aggressive B-cell lymphoma. |
KDR |
| 3 |
34219681 |
10.3233/TUB-211510 |
2021 |
Angiogenesis' related genetic variants alter clinical features and prognosis of diffuse large B-cell lymphoma patients. |
KDR |
| 4 |
32158186 |
10.2147/DDDT.S227477 |
2020 |
Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study. |
KDR |
| 5 |
32565964 |
10.3892/ol.2020.11552 |
2020 |
Comprehensive characterization of driver genes in diffuse large B cell lymphoma. |
KDR |
| 6 |
30423319 |
10.1016/j.ejphar.2018.11.012 |
2019 |
Apatinib exerts anti-tumor activity to non-Hodgkin lymphoma by inhibition of the Ras pathway. |
KDR |
| 7 |
31126146 |
10.3390/cells8050498 |
2019 |
c-Cbl: An Important Regulator and a Target in Angiogenesis and Tumorigenesis. |
KDR |
| 8 |
29854308 |
10.18632/oncotarget.25209 |
2018 |
Comparative oncology DNA sequencing of canine T cell lymphoma via human hotspot panel. |
KDR |
| 9 |
29864401 |
10.1016/j.yexcr.2018.05.038 |
2018 |
CS2164 exerts an antitumor effect against human Non-Hodgkin's lymphomas in vitro and in vivo. |
KDR |
| 10 |
30144594 |
10.1016/j.wneu.2018.08.080 |
2018 |
Aspirin Affects Tumor Angiogenesis and Sensitizes Human Glioblastoma Endothelial Cells to Temozolomide, Bevacizumab, and Sunitinib, Impairing Vascular Endothelial Growth Factor-Related Signaling. |
KDR |
| 11 |
27774879 |
10.2174/1570163813666161019143740 |
2017 |
Strong Anti-tumorous Potential of Nardostachys jatamansi Rhizome Extract on Glioblastoma and In Silico Analysis of its Molecular Drug Targets. |
KDR |
| 12 |
26879230 |
10.1161/CIRCRESAHA.115.307679 |
2016 |
Selective Targeting of a Novel Epsin-VEGFR2 Interaction Promotes VEGF-Mediated Angiogenesis. |
KDR |
| 13 |
26970956 |
10.1186/s40792-016-0152-7 |
2016 |
Dynamic computed tomography findings of an accessory spleen in the pelvis: a case report. |
KDR |
| 14 |
27365461 |
10.3324/haematol.2015.135475 |
2016 |
Whole exome sequencing in families at high risk for Hodgkin lymphoma: identification of a predisposing mutation in the KDR gene. |
KDR |
| 15 |
27806094 |
10.1371/journal.pone.0165876 |
2016 |
EGF-Induced VEGF Exerts a PI3K-Dependent Positive Feedback on ERK and AKT through VEGFR2 in Hematological In Vitro Models. |
KDR |
| 16 |
25689789 |
10.1016/j.bbmt.2014.12.027 |
2015 |
Content of endothelial progenitor cells in autologous stem cell grafts predict survival after transplantation for multiple myeloma. |
KDR |
| 17 |
23772669 |
10.3109/10428194.2013.813629 |
2014 |
Prognostic significance of immunohistochemical expression of the angiogenic molecules vascular endothelial growth factor-A, vascular endothelial growth factor receptor-1 and vascular endothelial growth factor receptor-2 in patients with classical Hodgkin lymphoma. |
KDR |
| 18 |
25289059 |
10.3892/etm.2014.1930 |
2014 |
Effect of a heat shock protein 90-specific inhibitor on the proliferation and apoptosis induced by VEGF-C in cervical cancer cells. |
KDR |
| 19 |
23624620 |
10.2340/00015555-1589 |
2013 |
Microvessel density and expression of vascular endothelial growth factor and its receptors in different subtypes of primary cutaneous B-cell lymphoma. |
KDR |
| 20 |
22129133 |
10.1111/j.1349-7006.2011.02168.x |
2012 |
VEGFA and VEGFR2 genetic polymorphisms and survival in patients with diffuse large B cell lymphoma. |
KDR |
| 21 |
22251800 |
10.1186/1471-2407-12-19 |
2012 |
DNA methylation regulates expression of VEGF-R2 (KDR) and VEGF-R3 (FLT4). |
KDR |
| 22 |
19211267 |
10.1016/j.carpath.2008.11.001 |
2010 |
Atrial fibrillation is associated with cardiac hypoxia. |
KDR |
| 23 |
19120365 |
10.1111/j.1365-2141.2008.07534.x |
2009 |
Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma. |
KDR |
| 24 |
19419943 |
10.2478/v10042-009-0004-4 |
2009 |
Soluble angiogenesis markers in gastric tumor patients. |
KDR |
| 25 |
19701853 |
10.1080/10428190903156729 |
2009 |
Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas. |
KDR |
| 26 |
20011623 |
10.1007/s12195-009-0069-3 |
2009 |
Shear Stress Regulates the Flk-1/Cbl/PI3K/NF-κB Pathway Via Actin and Tyrosine Kinases. |
KDR |
| 27 |
18461646 |
10.1002/hon.861 |
2008 |
Phosphorylated VEGFR2/KDR receptors are widely expressed in B-cell non-Hodgkin's lymphomas and correlate with hypoxia inducible factor activation. |
KDR |
| 28 |
19021062 |
10.1080/10428190802450629 |
2008 |
Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins. |
KDR |
| 29 |
17372230 |
10.1073/pnas.0700809104 |
2007 |
A critical role for the E3-ligase activity of c-Cbl in VEGFR-2-mediated PLCgamma1 activation and angiogenesis. |
KDR |
| 30 |
17488657 |
10.3324/haematol.10723 |
2007 |
Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients. |
KDR |
| 31 |
15693894 |
10.1111/j.1365-2559.2005.02081.x |
2005 |
The expression and cellular localization of phosphorylated VEGFR2 in lymphoma and non-neoplastic lymphadenopathy: an immunohistochemical study. |
KDR |
| 32 |
16305489 |
10.2174/156652405774641106 |
2005 |
Kinases as drug discovery targets in hematologic malignancies. |
KDR |
| 33 |
14996703 |
10.1182/blood-2003-08-2763 |
2004 |
VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. |
KDR |
| 34 |
12607599 |
10.1097/00129039-200212000-00005 |
2002 |
Immunohistochemical expression of basic fibroblast growth factor, vascular endothelial growth factor, and their receptors in stage IV non-Hodgkin lymphoma. |
KDR |
| 35 |
11378536 |
10.3109/10428190109057978 |
2001 |
Vascular endothelial growth factor/vascular permeability factor in the pathogenesis of primary effusion lymphomas. |
KDR |
| 36 |
10623771 |
10.1128/jvi.74.2.1038-1044.2000 |
2000 |
The human herpesvirus 8 homolog of Epstein-Barr virus SM protein (KS-SM) is a posttranscriptional activator of gene expression. |
KDR |
| 37 |
9973224 |
NA |
1999 |
Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. |
KDR |
Datasets
Models
